ATE225647T1 - Dosierungsform zur verabreichung von flüssige arzneimittel formulierung - Google Patents

Dosierungsform zur verabreichung von flüssige arzneimittel formulierung

Info

Publication number
ATE225647T1
ATE225647T1 AT94920203T AT94920203T ATE225647T1 AT E225647 T1 ATE225647 T1 AT E225647T1 AT 94920203 T AT94920203 T AT 94920203T AT 94920203 T AT94920203 T AT 94920203T AT E225647 T1 ATE225647 T1 AT E225647T1
Authority
AT
Austria
Prior art keywords
dosage form
administration
medicinal formulation
liquid medicinal
liquid
Prior art date
Application number
AT94920203T
Other languages
English (en)
Inventor
Steven D Larsen
George V Guittard
Patrick S-L Wong
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ATE225647T1 publication Critical patent/ATE225647T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT94920203T 1994-06-13 1994-06-13 Dosierungsform zur verabreichung von flüssige arzneimittel formulierung ATE225647T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1994/006723 WO1995034285A1 (en) 1994-06-13 1994-06-13 Dosage form for administering drug in liquid formulation

Publications (1)

Publication Number Publication Date
ATE225647T1 true ATE225647T1 (de) 2002-10-15

Family

ID=22242671

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94920203T ATE225647T1 (de) 1994-06-13 1994-06-13 Dosierungsform zur verabreichung von flüssige arzneimittel formulierung

Country Status (11)

Country Link
EP (1) EP0768867B1 (de)
JP (1) JP3901727B2 (de)
KR (1) KR100360636B1 (de)
AT (1) ATE225647T1 (de)
AU (1) AU682703B2 (de)
CA (1) CA2185119C (de)
DE (1) DE69431533T2 (de)
DK (1) DK0768867T3 (de)
ES (1) ES2183841T3 (de)
PT (1) PT768867E (de)
WO (1) WO1995034285A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5904935A (en) * 1995-06-07 1999-05-18 Alza Corporation Peptide/protein suspending formulations
US6673768B1 (en) 1997-10-16 2004-01-06 Board Of Regents, The University Of Texas System Transgenic animal models for cardiac hypertrophy and methods of use thereof (treating)
HK1038508B (en) * 1998-09-09 2006-06-30 Alza Corporation Dosage form comprising liquid formulation
PT1140012E (pt) * 1998-12-17 2004-05-31 Alza Corp Conversao de capsulas de gelatina cheias com liquido em sistemas de libertacao controlada por camadas multiplas
US7919109B2 (en) 1999-02-08 2011-04-05 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
US7258869B1 (en) 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
AR041744A1 (es) * 2002-10-31 2005-05-26 Alza Corp Formas de dosificacion que proporcionan la liberacion ascendente de una formulacion liquida
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
CA2540308C (en) 2003-09-26 2013-08-06 Alza Corporation Drug coating providing high drug loading and methods for providing the same
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
KR101106510B1 (ko) 2006-05-30 2012-01-20 인타르시아 세라퓨틱스 인코포레이티드 투피스, 내부채널 삼투압 전달 시스템 유동 조절기
EP2359808B1 (de) 2006-08-09 2013-05-22 Intarcia Therapeutics, Inc Osmotisches Verabreichungssystem mit Kolbenanordnung
WO2008133908A2 (en) 2007-04-23 2008-11-06 Intarcia Therapeutics, Inc. Suspension formulations of insulinotropic peptides and uses thereof
CA2691531C (en) 2007-06-22 2016-11-01 Board Of Regents,The University Of Texas System Formation of stable submicron peptide or protein particles by thin film freezing
CA2726861C (en) 2008-02-13 2014-05-27 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
EP2376522A4 (de) 2008-11-16 2013-12-25 Univ Texas Niederviskose hochkonzentrierte suspensionen
RU2547990C2 (ru) 2009-09-28 2015-04-10 Интарсия Терапьютикс, Инк. Быстрое достижение и/или прекращение существенной стабильной доставки лекарственного средства
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
TWI615155B (zh) * 2011-11-01 2018-02-21 拜耳股份有限公司 滲透活性的陰道遞送系統
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
RU2730996C2 (ru) 2015-06-03 2020-08-26 Интарсия Терапьютикс, Инк. Системы установки и извлечения имплантата
US20170119680A1 (en) * 2015-10-30 2017-05-04 R.P. Scherer Technologies, Llc Extended release film-coated capsules
KR102574993B1 (ko) 2016-05-16 2023-09-06 인타르시아 세라퓨틱스 인코포레이티드 글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
JP7286542B2 (ja) 2017-01-03 2023-06-05 インターシア セラピューティクス，インコーポレイティド Ｇｌｐ－１受容体アゴニストの持続的投与及び薬物の同時投与を含む方法
JP7195345B2 (ja) 2018-03-05 2022-12-23 アムニール コンプレックス プロダクツ リサーチ エルエルシー 薬物の時間放出のためのプログラム可能な医薬組成物
USD933219S1 (en) 2018-07-13 2021-10-12 Intarcia Therapeutics, Inc. Implant removal tool and assembly
CA3130379A1 (en) 2019-03-05 2020-09-10 Kashiv Biosciences, Llc Delayed release methylphenidate compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2155889B (en) * 1984-03-21 1988-03-02 Alza Corp Dispenser-capsule
US4814180A (en) * 1984-03-21 1989-03-21 Alza Corporation Agent dispenser comprising a semipermeable wall surrounding single-piece or two-piece container
US5324280A (en) * 1990-04-02 1994-06-28 Alza Corporation Osmotic dosage system for delivering a formulation comprising liquid carrier and drug

Also Published As

Publication number Publication date
EP0768867A1 (de) 1997-04-23
JP3901727B2 (ja) 2007-04-04
JPH10501261A (ja) 1998-02-03
PT768867E (pt) 2003-01-31
WO1995034285A1 (en) 1995-12-21
EP0768867B1 (de) 2002-10-09
DE69431533T2 (de) 2003-10-02
KR970703752A (ko) 1997-08-09
AU682703B2 (en) 1997-10-16
CA2185119C (en) 2005-07-26
DK0768867T3 (da) 2002-10-28
DE69431533D1 (de) 2002-11-14
AU7108094A (en) 1996-01-05
CA2185119A1 (en) 1995-12-21
KR100360636B1 (ko) 2002-12-18
ES2183841T3 (es) 2003-04-01

Similar Documents

Publication Publication Date Title
DE69431533D1 (de) Dosierungsform zur verabreichung von flüssige arzneimittel formulierung
DE69106501D1 (de) Osmotisches dosiersystem zur verabreichung von flüssigen arzneimitteln.
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
ATE96308T1 (de) Dosierform fuer verabreichung in der humanmedizin.
MX171191B (es) Composiciones farmaceuticas de glipizida
NO924209L (no) Doseringsform for tilfoersel av et antiparkinsonmiddel
DE69225135D1 (de) Dosierungsform zur verzoegerten wirkstofffreisetzung
ATE298561T1 (de) Orale dareichungsform
ES2089011T3 (es) Excipiente lipidico de administracion nasal y aplicacion topica.
IS1694B (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
NO874960L (no) Flytende doseringsform for oral administrasjon av et farmasoeytisk aktivt stoff.
ATE79619T1 (de) Arzneimittel.
ATE427103T1 (de) Orale verabreichung von adenosin analogen
ES2165997T3 (es) Uso de una formulacion farmaceutica pediatrica que comprende amoxicilina y clavulanato.
MY101784A (en) Novel pharmacological compounds
ATE292453T1 (de) Antivirale arznei
ES2160821T3 (es) Uso de una composicion que comprende amoxicilina y acido clavulanico para la produccion de un medicamento para el tratamiento de infecciones bacterianas en pacientes pediatricos.
BR9610983A (pt) Formas estáveis de administração farmacêuticas contendo paratormônio
PT705204E (pt) Saquetas para medicamentos liquidos
GR3022742T3 (en) New derivatives of non-steroidal anti-inflammatory, analgesic and/or antipyretic substances, their use and pharmaceutical formulations containing them
ATE173923T1 (de) Oralanzuwendende flüssige arzneizubereitung enthaltend 2-(4-isobutylphenyl)propionsäure
AU1935788A (en) A process for producing an administration and/or dosage form for medically active ingredients of drugs
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
FR2621248B1 (fr) Dispositif implantable dans l'organisme pour l'injection repetee de doses precises de substances medicamenteuses liquides
AU625402B2 (en) Transdermal system exhibiting graduated drug release and its use for the local or systemic administration of active substances

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee